Skip to main content

Table 2 Clinical and pathological features in the present case (case 1) and previously reported PSEN1-linked CWP-AD cases (cases 2–28)

From: Young adult-onset, very slowly progressive cognitive decline with spastic paraparesis in Alzheimer’s disease with cotton wool plaques due to a novel presenilin1 G417S mutation

Case

Sex

Age at onset (y)

Age at death (y)

Duration (y)

Initial symptoms

Spastic paraparesis

Parkinsonism

Brain weight (g)

CWPs

Lewy body disease

PSEN1 mutation

References

1

f

25

54

29

cognitive impairment

+

+

895

+

diffuse

G417S

Present case

2

n.d.

29

n.d.

n.d.

spastic paraparesis

+

n.d.

n.d.

+

n.d.

P436Q

Houlden H et al. [6]

3

m

30s

48

n.a.

disorientation

n.d.

n.d.

+

n.d.

L420R

Shrimpton AE et al. (II:1) [20]

4

f

31

43

12

forgetfulness

+

1170

+

L420R

Niwa A et al. [14]

5

m

34

39

5

morbid jealousy

n.d.

1550

+

n.d

deletion of exon 9 sequence from PSEN1 transcripts

Brooks WS et al. (EOFAD-2 IV:45) [3]

6

m

34

52

18

parkinsonism

+

1150

+

diffuse

in-frame 3bp ACC deletion in exon 12

Ishikawa A et al. [8]

7

n.d.

36

n.d.

n.d.

spastic paraparesis

+

n.d.

n.d.

+

n.d.

Δ83,84IM

Houlden H et al. [6]

8

f

37

50

13

cognitive dysfunction, parkinsonism

+

+

740

+

limbic

G217D

Takao M et al. (case III-2) [23]

9

f

40

biopsy

n.a.

cognitive impairment

+

n.d.

biopsy

+

n.d.

E280G

O’Riordan S et al. (patient 3) [17]

10

f

41

45

4

cognitive decline

n.d.

992

+

n.d.

G- > T exon 9 splice acceptor mutation

Brooks WS et al. (EOFAD-3 II:10) [3]

11

m

41

46

5

dementia

n.d.

n.d.

n.d.

+

n.d.

deletion of exon 9

Smith MJ et al. (case II:12) [22]

12

m

42

46

4

antiflexion gait

+

+

1150

+

G217D

Takao M et al. (case III-1) [23]

13

f

46

52

6

memory loss and disorientation

n.d.

1144

+

n.d.

G217R

Norton JB et al. (case 4:4) [15]

14

m

46

65

19

depression

+

+

1100

+

P264L

Martikinen P et al. (case 3) [12]

15

f

47

51

4

cognitive decline

+

n.d.

n.d.

+

n.d.

G- > T exon 9 splice acceptor mutation

Brooks WS et al. (EOFAD-3 II:8) [3]

16

m

47

67

20

spasticity and weakness in legs

+

n.d.

1110

+

E280G

Sinha N et al. [21]

17

f

50

53

3

spastic paraparesis

+

n.d.

n.d.

+

n.d.

deletion of exon 9

Smith MJ et al. (case III:9) [22]

18

f

50

60

10

cognitive decline

n.d.

918

+

n.d.

deletion of exon 9 sequence from PSEN1 transcripts

Brooks WS et al. (EOFAD-2 III:18) [3]

19

f

51

68

17

memory impairment

+

1050

+

P264L

Martikinen P et al. (case 1) [12]

20

m

52

56

4

cognitive decline

n.d.

910

+

n.d.

deletion of exon 9 sequence from PSEN1 transcripts

Brooks WS et al. (EOFAD-2 IV:23) [3]

21

m

52

56

4

dementia

n.d.

n.d.

n.d.

+

n.d.

deletion of exon 9

Smith MJ et al. (case II:7) [22]

22

m

52

67

15

memory difficulty and weakness in both legs

+

n.d.

890

+

n.d.

E280Q

Rogaeva E et al. [18]

23

f

54

63

9

dementia and spastic paraparesis

+

n.d.

n.d.

+

n.d.

deletion of exon 9

Smith MJ et al. case (III:7) [22]

24

m

54

64

10

dementia

+

n.d.

1360

+

n.d.

deletion of exon 9

Crook R et al. (case III:15) [4]

25

m

55

61

6

back pain, stiffness of legs

+

n.d.

n.d.

+

n.d.

deletion of exon 9 splice site

Crook R et al. (patient III:9) [4]

26

m

57

69

12

dementia

+

n.d.

1075

+

n.d.

deletion of exon 9

Crook R et al. (case III:14) [4]

27

m

58

75

17

memory impairment

+

1320

+

P264L

Martikinen P et al. (case 2) [12]

28

f

n.d.

60

n.a.

n.d.

n.d.

n.d.

+

n.d.

L271V

Kwok JB et al. (III:28) [10]

  1. Cases are shown in the order of the age at onset. m, male; f, female; +, present; −, absent; n.d., not described; n.a., not available; CWPs, cotton wool plaques; diffuse, diffuse neocortical type Lewy body disease [13]; limbic, limbic type Lewy body disease [13]